To validate the radiosensitizing effect of HOTAIRM1 knock-down in vivo, we investigated an orthotopic xenograft glioma model using LN-229 control and HOTAIRM1 knock-down cells. Here, HOTAIRM1 is linked to central nervous system cancer.